Between 2013 and 2023, the Insulin in Dosage Market size per capita in Ireland showed variations, peaking at $12.86 in 2021, then declining to $11.52 in 2023. The market experienced fluctuations with an average yearly change and diverse growth trends. Over the last two years, there have been significant year-on-year variations with a noted decline of about 9.41% from 2021 to 2022, followed by a smaller decrease in 2023. Over the last five years, the compound annual growth rate (CAGR) indicated a general downward trend, averaging a decrease of around 1.55% per year.
Future trends to watch include potential advancements in insulin delivery technology, increased prevalence of diabetes, and healthcare policy shifts which may influence insulin consumption and market size in Ireland.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 14 | 14 Japan | 13.48 | 2023 | View data | ||
| 15 | 15 Lithuania | 12.65 | 2023 | View data | ||
| 16 | 16 Ireland | 11.52 | 2023 | |||
| 17 | 17 Austria | 10.77 | 2023 | View data | ||
| 18 | 18 Poland | 8.14 | 2023 | View data | ||
